All In Biotech

Free tool

FAERS Monitor: Supprelin La

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022058 or its brand name (Supprelin La, Histrelin Acetate). Reports on generic versions are filed under their own applications.

Reports

877

Serious

186

21% of reports

Hospitalization

48

Death reported

28

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective138
  • device breakage117
  • procedural complication83
  • incorrect drug administration duration65
  • incorrect product administration duration60
  • rash46
  • implant site rash41
  • headache39
  • off label use34
  • weight increased31
  • mood swings28
  • device expulsion27
  • implant site pain27
  • implant site infection23
  • rash pruritic23

Reports by year received

View as table
YearReports
20082
20098
20107
201110
201211
2013220
201460
2015112
201671
201770
201845
201942
202039
202124
202242
202331
202445
202524
202614

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,282 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
implant site rashSignal413104.92258.0109,919
procedural complicationSignal83262.4213.621,134
implant site infectionSignal23239.5159.75,176
implant site painSignal27145.8100.43,717
device breakageSignal11769.358.57,803
incorrect product administration durationSignal6066.652.23,805
incorrect drug administration durationSignal6555.543.93,424
mood swingsSignal2821.114.6516
rash pruriticSignal2310.26.8182
device expulsionSignal2710.06.9210
weight increasedSignal313.32.348
rashSignal462.51.942
drug ineffectiveSignal1382.52.2132
headache391.51.16
off label use340.90.70

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.